APA (7th ed.) Citation

Marbury, T. C., Flint, A., Jacobsen, J. B., Derving Karsbøl, J., & Lasseter, K. (2017). Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment. Clinical pharmacokinetics, 56(11), 1381-1390. https://doi.org/10.1007/s40262-017-0528-2

Chicago Style (17th ed.) Citation

Marbury, Thomas C., Anne Flint, Jacob B. Jacobsen, Julie Derving Karsbøl, and Kenneth Lasseter. "Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment." Clinical Pharmacokinetics 56, no. 11 (2017): 1381-1390. https://doi.org/10.1007/s40262-017-0528-2.

MLA (9th ed.) Citation

Marbury, Thomas C., et al. "Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment." Clinical Pharmacokinetics, vol. 56, no. 11, 2017, pp. 1381-1390, https://doi.org/10.1007/s40262-017-0528-2.